TED (EU)
Spain – Various medicinal products – Suministro del principio activo denominado "BLINATUMOMAB 38,5 MCG VIAL POLVO INTRAVENOSA "para el Hospital Universitario de Gran Canaria Dr. Negrín.
Awarded
EU
29
Key details
Region
Spain
Delivery: ES705, ESP
Sector
Contract value
Not stated by buyer
Submissions closed
Not stated by buyer
Published
25 June 2026
Procurement
Procedure type
neg-wo-call
Evaluation method
price
CPV classifications
- 33690000 Various medicinal products
What happened
The buyer awarded this contract to AMGEN, S.A worth €115,385 on 3 Jun 2026.
Description
El objeto del contrato viene determinado por el suministro del principio activo denominado "BLINATUMOMAB 38,5 MCGVIAL POLVO INTRAVENOSA " para el Hospital Universitario de Gran Canaria Dr. Negrín.Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común deContratos (CPV) de la Comisión Europea.
Awarded supplier
Supplier
AMGEN, S.A
Award value
€115,385
Award date
3 June 2026
Contact
Address
Las Palmas de Gran Canaria, 35019
Contact name
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Email
Phone
Explore related tenders
External ID: ted-440484-2026 • Added 26 June 2026